Correlation Between Relay Therapeutics and Immix Biopharma
Can any of the company-specific risk be diversified away by investing in both Relay Therapeutics and Immix Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Relay Therapeutics and Immix Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Relay Therapeutics and Immix Biopharma, you can compare the effects of market volatilities on Relay Therapeutics and Immix Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Relay Therapeutics with a short position of Immix Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Relay Therapeutics and Immix Biopharma.
Diversification Opportunities for Relay Therapeutics and Immix Biopharma
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Relay and Immix is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Relay Therapeutics and Immix Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immix Biopharma and Relay Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Relay Therapeutics are associated (or correlated) with Immix Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immix Biopharma has no effect on the direction of Relay Therapeutics i.e., Relay Therapeutics and Immix Biopharma go up and down completely randomly.
Pair Corralation between Relay Therapeutics and Immix Biopharma
Given the investment horizon of 90 days Relay Therapeutics is expected to under-perform the Immix Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Relay Therapeutics is 2.1 times less risky than Immix Biopharma. The stock trades about -0.3 of its potential returns per unit of risk. The Immix Biopharma is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 164.00 in Immix Biopharma on August 25, 2024 and sell it today you would earn a total of 15.00 from holding Immix Biopharma or generate 9.15% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Relay Therapeutics vs. Immix Biopharma
Performance |
| Timeline |
| Relay Therapeutics |
| Immix Biopharma |
Relay Therapeutics and Immix Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Relay Therapeutics and Immix Biopharma
The main advantage of trading using opposite Relay Therapeutics and Immix Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Relay Therapeutics position performs unexpectedly, Immix Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immix Biopharma will offset losses from the drop in Immix Biopharma's long position.| Relay Therapeutics vs. Stoke Therapeutics | Relay Therapeutics vs. Pliant Therapeutics | Relay Therapeutics vs. Black Diamond Therapeutics | Relay Therapeutics vs. Arvinas |
| Immix Biopharma vs. ZyVersa Therapeutics | Immix Biopharma vs. Hepion Pharmaceuticals | Immix Biopharma vs. Cns Pharmaceuticals | Immix Biopharma vs. Sonnet Biotherapeutics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |